Hyperfine HYPR
NASDAQ HYPR
$0.90 0.00 (-0.22%)
At close: Aug 21, 2026 · 4:00 PM EDT

Hyperfine (HYPR) Liabilities and Shareholders Equity (2020 - 2026)

Hyperfine's (HYPR) quarterly Liabilities and Shareholders Equity came in at $60.3 million in Q1 2026, up 13.04% YoY from $53.4 million in Q1 2025, and up 9.19% on a QoQ basis from $55.3 million in Q4 2025.

Hyperfine (HYPR) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Hyperfine (HYPR) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $60.3 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 13.04% year-over-year to $60.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.3 million (down 21.65% YoY) and the FY2025 annual result came in at $55.3 million, down 6.18% from the prior year.
  • Liabilities and Shareholders Equity improved to $60.3 million in Q1 2026, from $55.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $178.8 million in Q1 2022 to a low of $41.5 million in Q3 2025.
  • A 5-year average of $94.2 million and a median of $85.4 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity sank 40.96% — and 2026, when it increased 13.04%.
  • Tracing HYPR's Liabilities and Shareholders Equity over 5 years: stood at $134.1 million in 2022, then retreated by 29.73% to $94.2 million in 2023, then sank by 37.47% to $58.9 million in 2024, then decreased by 6.18% to $55.3 million in 2025, then climbed by 9.19% to $60.3 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $60.3 million (Q1 2026), $55.3 million (Q4 2025), and $41.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 109.22 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 13.87 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 31.04 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 10.74 Bn
10 Hyperfine 89.83 Mn 45.06 Mn 1.98 Mn 63.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 63.00 Mn
Mar 31, 2026 60.34 Mn
Dec 31, 2025 55.26 Mn
Sep 30, 2025 41.51 Mn
Jun 30, 2025 45.23 Mn
Mar 31, 2025 53.38 Mn
Dec 31, 2024 58.90 Mn
Sep 30, 2024 69.39 Mn
Jun 30, 2024 76.61 Mn
Mar 31, 2024 85.44 Mn
Dec 31, 2023 94.20 Mn
Sep 30, 2023 103.06 Mn
Jun 30, 2023 112.61 Mn
Mar 31, 2023 122.10 Mn
Dec 31, 2022 134.05 Mn
Sep 30, 2022 148.33 Mn
Jun 30, 2022 161.71 Mn
Mar 31, 2022 178.83 Mn
Dec 31, 2021 202.47 Mn
Sep 30, 2021 207.94 Mn